Connection

Andrew Kraft to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Andrew Kraft has written about Antibodies, Monoclonal, Humanized.
Andrew Kraft
Connection Strength
1.283
Antibodies, Monoclonal, Humanized
  1. Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report. J Med Case Rep. 2021 Jul 24; 15(1):400.
    View in: PubMed
    Score: 0.716
  2. Angiosarcoma treated successfully with anti-PD-1 therapy - a case report. J Immunother Cancer. 2017 07 18; 5(1):58.
    View in: PubMed
    Score: 0.542
  3. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial. Lancet Oncol. 2013 Apr; 14(4):371-82.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.